BDBM72425 2,8-Difluoro-13,13-dimethyl-3-(trifluoromethyl)-10,11,12,13-tetrahydro-19H-5,18-methanodibenzo[c,f]pyrido[3,2-j][1,5,9]triazacyclotridecine-15,19(14H)-dione::US20250368647, Example 134

SMILES CC1(C)CNCc2cc(F)ccc2N2CN(C(=O)c3cc(F)c(C(F)(F)F)cc32)c2ccc(=O)[nH]c21

InChI Key InChIKey=JFPHQGQBAXZMRK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72425   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72425BDBM72425(2,8-Difluoro-13,13-dimethyl-3-(trifluoromethyl)-10...)
Affinity DataIC50: 50.1nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent